William Z. Levine, DDS
Dr. Bill Levine is the founder of Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in Botanical Medicine. This area of specialty pharma develops pharmaceutical and healthcare products from plant-based sources. Bill, who received his DDS degree and specialty training in Periodontics from Columbia University, initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. Izun has also developed wound care products, oncology support products, and products targeting women's health care.
Subsequently, recognizing the Izun expertise in botanicals, Bill applied this knowledge to the cannabis plant and established CannRx. In a short time, CannRx has developed validated assays (receiving ISO 17025 service laboratory certification) and new and differentiated delivery systems. CannRx has identified & licensed new potent strains and appears well on its way to establishing itself as a leading plater in the cannabis field.
GABRIEL NUSSBAUM, MD, PhD
Director of Scientific Affairs
Dr. Nussbaum trained and was US board-certified in internal medicine after completing an MD/PhD at the Albert Einstein College of Medicine. He performed post-doctoral studies at the Weizmann Institute of Science, an internationally known research center in Israel. He continues to be actively involved in the investigation of inflammation and autoimmunity. In addition , Dr. Nussbaum has research experience with botanicals, specifically cannabis. Dr. Nussbaum has numerous publications in leading scientific journals.
Mr. Kraus commenced as COO of Izun in 2013. For the 12 years prior to this, Les served as Chief Financial Officer of Retail Apparel Group Pty Ltd (RAG), the largest menswear retailer in Australia. During his time at RAG, Les managed two sale processes to private equity firms. He is a qualified Chartered Accountant in Australia and has over 30 years of operational and financial experience within the clothing industry, covering both retail and wholesale businesses.
SHIMON LECHT, PhD,R.Ph.
R&D Team Manager
Dr. Lecht recently joined the CannRx team to lead the R&D. He is an experienced multidisciplinary basic and translational researcher. Dr. Lecht brings along a valuable experience in pre-clinical project management from early discovery to clinical trials. Prior to joining CannRx, Dr. Lecht took a leading part in several botanical drug development projects, provided regulatory services to bio-tech start-up companies towards first interaction with FDA and co-founded a pharmaceutical consulting company.
Dr. Lecht completed a post-doctoral training in Regenerative Medicine (Temple University, PA), holds a PhD and an MSc in Pharmacology from the Hebrew University in Jerusalem and is a licensed pharmacist in Israel.
Dr. Lecht published numerous peer-reviewed publications and presented at dozens of international meetings and conferences.
Some facts about us!
Dr. Nussbaum has numerous publications in leading scientific journals.
Mr. Kraus is a qualified Chartered Accountant in Australia and has over 30 years of operational and financial experience
CannRx Technology Inc.
One Rockefeller Plaza, 11th Floor
New York, NY 10020
© 2016 Copyright by CannRx Technology Inc. All Rights Reserved.